Rehabilitation Equipment Market Set To Grow To $13.06 Bn By 2021

08 August 2018
Pharma

Visiongain has launched a new Pharmaceutical Report Global Rehabilitation Equipment Market 2017-2027: Revenue Forecasts for Rehabilitation Equipment, Daily Living Aids, Mobility Equipment, Body Support Devices and Exercise Equipment

The report forecasts the rehabilitation equipment market will multiply in revenues from 2017 to 2027. The pharmaceutical segment is evolving. Visiongain reports the strength of the rehabilitation equipment market is its daily living aids segment, which generated revenues of $3.42bn. Rising prevalence of severe disabling conditions and rising number of people living with disability are the prime factors that support the growth of the rehabilitation equipment globally. According to World Health Organization, the prevalence of disability among populations has increased by 25% since 2005. This, steep increase in this patient population segment propels the use of rehabilitation equipment. In addition, prevalence of non-communicable diseases, rising incidence of disabilities and favourable healthcare reforms in developing countries and increasing awareness will drive the growth of the rehabilitation equipment market

The global rehabilitation equipment market is expected to grow owing to factors such as increasing disposable income coupled with favourable government policies in developed countries to meet the needs of geriatric and physically challenged population. In addition, increasing healthcare awareness and healthcare infrastructure development in the developing economies will drive the growth of the rehabilitation equipment market.
Technological advancements and increasing healthcare awareness among the patient population are some of the prominent factors that are expected to support the growth of the global rehabilitation equipment market during the forecast period from 2016 to 2027.” - Visiongain medical devices industry analyst

The new report shows revenue forecasts to 2027 at overall world market, submarket, product and national level. It forecasts these world-level submarkets:

• Daily Living Aids
• Mobility Equipment
• Body Support Devices
• Exercise Equipment

This investigation predicts revenues of ten leading products in the market, including Medical beds, Reading, Writing and Computing Aids, Bathroom and Toilet Assist Devices, Wheelchairs and Scooters, Walking Assist Devices, Medical Lifting Sling, Patient Lifts, Lower Body Exercise Equipment, Upper Body Exercise Equipment and Total Body Exercise Equipment.
Revenue forecasts are also included of Research, data and analyses covering activities of Carex Health Brands, Caremax, Drive DeVilbiss Healthcare, Dynatronics Corporation, GF Health Products, Inc.,Hospital Equipment Manufacturing Company, Invacare Coporation, Medline Industries, Inc, Roma Medical Aids.

Analyses cover R&D and commercial news and predicts revenues to 2027 in leading regional markets. This includes the US, Japan, Germany, the UK, France, Italy, Spain (EU5 group), Brazil, Russia, India, China and South Korea.

Global rehabilitation Equipment Market 2017-2027 adds to visiongain’s range of reports on industries and markets in healthcare. Together these studies cover medical devices, diagnostics and pharmaceuticals.

Leading companies featured in the report who are developing rehabilitation equipment include Carex Health Brands, Caremax, Drive DeVilbiss Healthcare, Dynatronics Corporation, GF Health Products, Inc.,Hospital Equipment Manufacturing Company, Invacare Coporation, Medline Industries, Inc, Roma Medical Aids.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Oncology remains the largest disease area in the pharmaceutical business. The oncology market is dominated by big pharma companies and high price labels” says Visiongain report

Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.

10 September 2019

Read

“Anti-Infective Agents market set to grow to $141bn by 2024” says new Visiongain report

The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.

09 September 2019

Read

“Global thyroid gland disorder treatment market is anticipated to grow at a lucrative CAGR of 3.6% and anticipated to reach USD 3.21 Billion by 2029”, says Visiongain report.

Thyroid disease is one of today’s most prevalent hormonal illnesses. Hyperthyroidism, hypothyroidism, and thyroid nodules are the most common thyroid gland disorders.

05 September 2019

Read

“Global somatostatin analogs market is anticipated to grow at a lucrative CAGR of 5.3% and anticipated to reach USD 4.78 Bn by 2029”, says Visiongain report.

Somatostatin was used to diagnose gastrointestinal tract tumors and acromegaly in the clinical environment.

05 September 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever